Literature DB >> 1556188

Ultraviolet-irradiated monocytes efficiently inhibit the intracellular replication of Mycobacterium avium intracellulare.

W S Mirando1, H Shiratsuchi, K Tubesing, H Toba, J J Ellner, C A Elmets.   

Abstract

The purpose of this study was to evaluate the effect of ultraviolet (UV) radiation on the antimicrobial activities of monocytes for the intracellular pathogen Mycobacterium avium intracellulare (MAI). UV radiation augmented monocyte antimicrobial activity for MAI in a dose-dependent fashion. UVB doses of greater than or equal to 25 J/m2 resulted in a 50-100-fold reduction in MAI growth 7 d after initiation of culture. The increased monocyte antibacterial effect could be blocked by a plate glass filter, indicating that wavelengths within the UVB were responsible for the effect. UV radiation did not stimulate monocyte phagocytosis, and enhanced inhibition of MAI growth was observed in populations of adherent mononuclear cells that were devoid of T cells. This suggested that UV radiation acted directly to augment intrinsic monocyte antimicrobial activities. The administration of 8-methoxypsoralen plus UVA radiation to monocytes also augmented their antimicrobial activities against MAI. UV radiation thus may serve as a unique agent by which to evaluate the mechanisms by which mononuclear phagocytes control the growth of MAI.

Entities:  

Mesh:

Year:  1992        PMID: 1556188      PMCID: PMC442989          DOI: 10.1172/JCI115713

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

Review 1.  Nontuberculous mycobacteria and associated diseases.

Authors:  E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1979-01

2.  Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome.

Authors:  H W Murray; B Y Rubin; H Masur; R B Roberts
Journal:  N Engl J Med       Date:  1984-04-05       Impact factor: 91.245

3.  Long-term results of medical treatment in Mycobacterium intracellulare infection.

Authors:  A K Dutt; W W Stead
Journal:  Am J Med       Date:  1979-09       Impact factor: 4.965

4.  Inhibition by streptomycin of tubercle bacilli within cultured human macrophages.

Authors:  A J Crowle; J A Sbarbaro; F N Judson; G S Douvas; M H May
Journal:  Am Rev Respir Dis       Date:  1984-11

5.  Disseminated Mycobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency.

Authors:  P Zakowski; S Fligiel; G W Berlin; L Johnson
Journal:  JAMA       Date:  1982-12-10       Impact factor: 56.272

6.  Treatment of disease due to Mycobacterium intracellulare.

Authors:  P T Davidson; V Khanijo; M Goble; T S Moulding
Journal:  Rev Infect Dis       Date:  1981 Sep-Oct

7.  Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Clinical features and course in 100 consecutive cases.

Authors:  D Y Rosenzweig
Journal:  Chest       Date:  1979-02       Impact factor: 9.410

8.  Medical therapy of Mycobacterium avium-intracellulare pulmonary disease.

Authors:  E T Etzkorn; S Aldarondo; C K McAllister; J Matthews; A J Ognibene
Journal:  Am Rev Respir Dis       Date:  1986-09

9.  Hairy cell leukemia: association with disseminated atypical mycobacterial infection.

Authors:  R A Weinstein; H M Golomb; G Grumet; E Gelmann; G P Schechter
Journal:  Cancer       Date:  1981-07-15       Impact factor: 6.860

Review 10.  Interferon-gamma, the activated macrophage, and host defense against microbial challenge.

Authors:  H W Murray
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

View more
  1 in total

1.  Resolution of Crohn's disease and complex regional pain syndrome following treatment of paratuberculosis.

Authors:  J Todd Kuenstner; William Chamberlin; Saleh A Naser; Michael T Collins; Coad Thomas Dow; John M Aitken; Stuart Weg; Grzegorz Telega; Kuruvilla John; David Haas; Torsten M Eckstein; Maher Kali; Christine Welch; Thomas Petrie
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.